Published in Am Heart J on July 01, 2010
Understanding the epidemic of heart failure: past, present, and future. Curr Heart Fail Rep (2014) 1.12
Palliative care and hospice in advanced heart failure. Prog Cardiovasc Dis (2011) 0.96
Year in review: medication mishaps in the elderly. Am J Geriatr Pharmacother (2011) 0.86
Hospice care and resource utilization in Medicare beneficiaries with heart failure. Med Care (2011) 0.84
Randomized, Controlled Trial of an Advance Care Planning Video Decision Support Tool for Patients With Advanced Heart Failure. Circulation (2016) 0.81
Team-based Palliative and End-of-life Care for Heart Failure. Heart Fail Clin (2015) 0.79
Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective. Br J Cancer (2016) 0.79
Hospice Enrollment in Patients With Advanced Heart Failure Decreases Acute Medical Service Utilization. Circ Heart Fail (2017) 0.75
A Place to Get Worse: Perspectives on Avoiding Hospitalization from Patients with End-Stage Cardiopulmonary Disease. J Hosp Palliat Nurs (2014) 0.75
Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life. Clin Gastroenterol Hepatol (2017) 0.75
Symptom burden in heart failure: assessment, impact on outcomes, and management. Heart Fail Rev (2017) 0.75
A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol (2004) 42.68
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol (2005) 8.77
Sudden cardiac death in the United States, 1989 to 1998. Circulation (2001) 7.92
Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care (2005) 7.73
Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care (2005) 4.30
More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail (2001) 4.29
Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med (2008) 3.48
Prognosis communication in serious illness: perceptions of older patients, caregivers, and clinicians. J Am Geriatr Soc (2003) 3.13
Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care (2005) 2.75
Understanding the experience of pain in terminally ill patients. Lancet (2001) 2.66
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65
Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J (2007) 2.55
The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med (2004) 2.17
Changing preferences for survival after hospitalization with advanced heart failure. J Am Coll Cardiol (2008) 1.96
An alternative in terminal care: results of the National Hospice Study. J Chronic Dis (1986) 1.88
Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan hospital automated database. Epidemiology (1996) 1.87
The last six months of life for patients with congestive heart failure. J Am Geriatr Soc (2000) 1.82
Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol (2006) 1.75
Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol (2008) 1.70
Comparing the quality of death for hospice and non-hospice cancer patients. Med Care (1988) 1.67
Range and severity of symptoms over time among older adults with chronic obstructive pulmonary disease and heart failure. Arch Intern Med (2007) 1.63
Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med (2009) 1.62
Geographic variation in hospice use in the United States in 2002. J Pain Symptom Manage (2007) 1.35
Racial disparity in hospice use in the United States in 2002. Palliat Med (2008) 1.35
Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Card Fail (2006) 1.25
Physician attitudes toward end-stage heart failure: a national survey. Am J Med (2008) 1.14
Preferences for treatment outcomes in patients with heart failure: symptoms versus survival. J Card Fail (2000) 1.10
Hospice use among patients with heart failure. Am Heart J (2009) 1.08
End-of-life preferences in elderly patients admitted for heart failure. QJM (2004) 1.08
Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study. Eur J Heart Fail (2002) 0.99
Hospice role in alleviating the emotional stress of terminal patients and their families. Med Care (1985) 0.95
Ensuring palliative medicine availability: the development of the IAHPC list of essential medicines for palliative care. J Pain Symptom Manage (2007) 0.92
Understanding their options: determinants of hospice discussion for older persons with advanced illness. J Gen Intern Med (2009) 0.90
Hospice as an alternative model of care for older patients with end-stage heart failure. J Cardiovasc Nurs (2004) 0.90
Patients with heart failure who die in hospice. Am Heart J (2005) 0.90
Hospice care for heart failure patients. J Pain Symptom Manage (2005) 0.90
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (2009) 10.52
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31
Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47
Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25
Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13
Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med (2014) 4.99
Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA (2011) 4.73
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
The comparative safety of analgesics in older adults with arthritis. Arch Intern Med (2010) 4.47
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet (2012) 4.46
Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 4.40
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol (2005) 4.26
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet (2010) 4.07
Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med (2002) 4.07
Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol (2009) 3.99
A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J (2004) 3.37
Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33
Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J (2007) 3.21
Medical management of advanced heart failure. JAMA (2002) 3.07
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04
High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation (2013) 3.03
Confounding control in healthcare database research: challenges and potential approaches. Med Care (2010) 3.01
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98
Hetastarch and bleeding complications after coronary artery surgery. Chest (2003) 2.87
Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med (2002) 2.85
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med (2002) 2.82
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm (2008) 2.75
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol (2010) 2.74
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation (2003) 2.73
The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med (2010) 2.71
Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol (2008) 2.66
Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res (2003) 2.65
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol (2008) 2.58
Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) (2009) 2.56
Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56
Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol (2005) 2.55
Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J (2007) 2.55
Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach. Biometrics (2003) 2.49
Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47
The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail (2002) 2.45
Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42
Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med (2013) 2.39
Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology (2005) 2.38
Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.37
Racial differences in screening for prostate cancer in the elderly. Arch Intern Med (2004) 2.34
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31
Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation (2009) 2.26
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 2.23
A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med (2007) 2.20
Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum (2007) 2.18
INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant (2008) 2.17
Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol (2012) 2.14
Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making (2006) 2.12
Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol (2003) 2.09
Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy. J Clin Epidemiol (2002) 2.09
C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol (2004) 2.08
A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes (2004) 2.03
Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation (2005) 2.02
Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc (2012) 1.99
Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. CMAJ (2002) 1.99
Insights into different results from different causal contrasts in the presence of effect-measure modification. Pharmacoepidemiol Drug Saf (2006) 1.99
Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation (2009) 1.97
Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum (2006) 1.95
The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood) (2009) 1.95
Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum (2006) 1.94
The effect of cigarette smoking on gingival bleeding. J Periodontol (2004) 1.91
Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol (2003) 1.87
Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med (2004) 1.86
Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation (2006) 1.85